Introduction
============

Colonoscopy has been shown to prevent colorectal cancer [@JR1635-1] and deaths from colorectal cancer [@JR1635-2] . The key to this effect is the detection and resection of premalignant polyps. Colonoscopy and polypectomy have been shown to be inversely related to post-colonoscopy colorectal cancer (PCCRC) and death from PCCRC [@JR1635-3] . This effect is likely to be smaller than is potentially achievable since polypectomy has been shown to be commonly incomplete, particularly depending on the operator and the size and type of polyp [@JR1635-4] .

The effectiveness of polypectomy is limited by several factors. Training in polypectomy is not standardized nor is it a focus in many countries. Many practitioners work in relatively isolated environments and receive little feedback on their technique or the occurrence of adverse events including PCCRC following their procedures. Importantly, until recently, there was no evidence-based guideline upon which to base decisions about the most effective polypectomy technique to be used in specific situations.

Moreover, recent advances have led to key principles in polypectomy practice. Avoidance of diathermy-related adverse events for resection of small and diminutive (\< 10 mm) polyps through the use of cold snare polypectomy (CSP) is well established [@JR1635-5] [@JR1635-6] [@JR1635-7] [@JR1635-8] [@JR1635-9] [@JR1635-10] . There is also strong evidence for the superiority of endoscopic resection versus surgery for predicted-benign large colorectal neoplasia [@JR1635-11] [@JR1635-12] [@JR1635-13] [@JR1635-14] . There is no published evidence as to whether these messages have reached the wider international community of endoscopists.

The European Society of Gastrointestinal Endoscopy (ESGE) has recently released a thoroughly researched position statement [@JR1635-11] with evidence-based guidelines for the optimal polypectomy technique based on size of polyp. The recommendations are summarized in [Fig. 1](#FI1635-1){ref-type="fig"} . The aim of this study was to compare the stated practice of endoscopists in seven countries with this synthesis of the best available contemporary evidence.

![ Overview of recommendations from the guideline. Evidence-based recommendations from the ESGE Colorectal Polypectomy Guideline 2017 [@JR1635-11] represented graphically. This flow diagram was used to assess adherence of participant responses in the study. CSP, cold snare polypectomy; CBF, cold biopsy forceps polypectomy; EMR, endoscopic mucosal resection or hot snare polypectomy with a submucosal lift; HSP, hot snare polypectomy without submucosal lifting; ESD, endoscopic submucosal dissection; SMIC, submucosal invasive cancer. \*Consider ESD correct only if rectal and if morphology suggests higher risk for submucosal invasive cancer. \*\*Outside the rectum or endoscopic imaging evidence of deep SMIC.](10-1055-a-1079-4298-i1635ei1){#FI1635-1}

Methods
=======

Definitions
-----------

Throughout this manuscript, "the guideline" refers to the ESGE Colorectal Polypectomy Guideline 2017 [@JR1635-11] . Participant refers to a single endoscopist taking the survey.

Detailed demographic information was collected from participants. In this study, the term "physician" is used to describe a medically trained endoscopist (gastroenterologist). Cold biopsy forceps polypectomy (CBF) refers to the use of a biopsy forceps to remove a polyp in one or more bites. CSP refers to the use of any endoscopic snare to mechanically resect a polyp without the use of diathermy. Hot snare polypectomy (HSP) refers to the use of any endoscopic resection snare to resect a polyp using diathermy without injection of a submucosal lifting solution. HSP with a prior submucosal lift is referred to as endoscopic mucosal resection (EMR). Endoscopic submucosal dissection (ESD) describes the use of an electrosurgical knife to circumferentially incise the mucosa and then dissect the polyp en bloc. Right colon location is defined as proximal to and including the hepatic flexure. Surgical referral describes referral to a surgeon for a traditional surgical resection.

Polyp size categories were \< 10 mm, 10--19 mm, and ≥20mm. Correct management for each category was assigned according to the technique(s) recommended in the guideline ( [Fig. 1](#FI1635-1){ref-type="fig"} ), as a surrogate for the best available contemporary evidence with which colonoscopic practitioners would be expected to be up-to-date. Pedunculated polyps were intentionally excluded from the images and the discussion.

Survey design
-------------

Survey questions were based on the standards set forth in the guideline. All authors were required to answer all questions in the first draft of the survey. The final survey reflected refinements based on their responses and suggestions. All authors reviewed and agreed the final version of the survey.

Participating countries were Australia, Belgium, Canada, Israel, New Zealand, UK, and USA. The only differences between survey versions sent to endoscopists in different countries were in the questions regarding demographics. Institutional review board approval for the survey design was obtained from Western Sydney Local Health District Human Research Ethics Committee and individual countries as required.

The survey contained three sections--participant demographics, images of specific polyps and questions regarding correct polypectomy techniques, and questions regarding the nuances of polypectomy.

The section presenting eight still images of specific polyps ( [Fig. 2](#FI1635-2){ref-type="fig"} ) constituted the majority of the survey. Participants were asked to specify the technique they would use in their daily practice to resect the displayed polyp. The images were chosen and agreed by the investigators as typical examples of the polyp size categories presented in the guideline. All techniques were presented as possibilities for every polyp.

![ Images of polyps presented to study participants stratified by size with resection technique or decision to refer. The text beneath the polyp images represents the exact text presented to the survey participants. Green typeface indicates a correct response when compared with the ESGE Colorectal Polypectomy Guideline. Cold snare, cold snare polypectomy; Cold biopsy, cold biopsy forceps polypectomy; Hot snare, hot snare polypectomy without submucosal lifting; EMR, endoscopic mucosal resection (hot snare polypectomy with prior submucosal lifting); Hot biopsy, hot biopsy forceps polypectomy; Correct, indicates percentage of respondents who chose a correct response as defined by the ESGE Colorectal Polypectomy Guideline. A small minority of respondents chose responses not included on this figure and so percentages do not necessarily add up to 100 %.](10-1055-a-1079-4298-i1635ei2){#FI1635-2}

Dissemination
-------------

Gastrointestinal endoscopy societies of the countries involved were contacted by the investigators and invited to participate in the survey. Participating societies sent an email to members of their mailing lists. The USA version of the survey was disseminated using a marketing mailing list ( **Supplementary Table 1** ). The online survey tool (SurveyMonkey, San Mateo, California, United States) recorded the IP address of each respondent. Each participant was asked to enter a random unique identifier at the end of the survey to protect against multiple responses from an individual.

Emails were sent in all countries within July 2017. Two weeks later, a reminder email was sent. After 4 weeks, the survey was closed and the responses analyzed.

Analysis
--------

The study data were analyzed using IBM SPSS Statistics, Version 23 (IBM Corp, Armonk, New York, United States). Incomplete responses were not analyzed. Categorical variables were correlated using the chi-squared test. Continuous variables were analyzed using either Student *t* test (two-tailed) or Mann--Whitney *U* test. If categorized, continuous data were described using the median value. All authors had access to the study data and reviewed the final manuscript.

Results
=======

In total, 19 467 endoscopists in seven countries received the survey; 772 (4.0 %) responded and 707 (91.7 %) completed the survey.

Demographic data ( **Supplementary Table 2** )
----------------------------------------------

In total, 162/707 respondents identified their location of practice as Australia, 102 Belgium, 60 Canada, 52 Israel, 45 New Zealand, 131 the UK, and 155 the USA. **Supplementary Table 2** shows per country responses. In total, 627/707 (88.7%) were gastroenterologists, 71 (10.0 %) were surgeons, and 9 (1.3 %) were nurse endoscopists; 63 (8.9 %) were trainees; 312 (44.1 %) identified their practice as academic.

Respondents had performed endoscopy for a median of 18 years (IQR 10--27) and most commonly performed \> 20 colonoscopies per week (25.9 %); 327 (46.3 %) had undertaken a specific endoscopy training attachment of ≥ 6 months and 243 (34.4 %) received tertiary referrals for polypectomy.

Polyp analysis and resection ( [Fig. 2](#FI1635-2){ref-type="fig"} , [Table 1](#TB1635-1){ref-type="table"} , [Fig. 2 and 3](#FI1635-2){ref-type="fig"} )
---------------------------------------------------------------------------------------------------------------------------------------------------------

All polyps presented in the survey and the responses regarding their management in the daily practice of respondents are displayed in [Fig. 2](#FI1635-2){ref-type="fig"} . Subgroup analyses of these responses by demographic are presented in [Fig. 3](#FI1635-3){ref-type="fig"} (practitioner type), [Table 1](#TB1635-1){ref-type="table"} (practitioner type, trainee status, undertaking of a specific endoscopy attachment, referral endoscopist, performing 11 + or 20 + colonoscopies per week, academic location of practice, performing 17 + EMRs per year, and 18 + years of total practice), and **Supplementary Fig. 1** (country of practice). Correctness of responses was assessed using the flow reported in [Fig. 1](#FI1635-1){ref-type="fig"} .

![ Images of polyps presented to study participants stratified by size with resection technique or decision to refer further stratified by type of practitioner. The text beneath the polyp image represents the exact text presented to the survey participants. Green typeface indicates a correct response when compared with the ESGE Colorectal Polypectomy Guideline. Phys, physician; Surg, surgeon; Cold snare, cold snare polypectomy; Cold biopsy, cold biopsy forceps polypectomy; Hot snare, hot snare polypectomy without submucosal lifting; EMR,--endoscopic mucosal resection (hot snare polypectomy with prior submucosal lifting); Hot biopsy, hot biopsy forceps polypectomy; Correct, indicates percentage of respondents who chose a correct response as defined by the ESGE Colorectal Polypectomy Guideline. Nurse endoscopists are excluded from this figure, total n = 698. A small minority of respondents chose responses not included on this figure and so percentages do not necessarily add up to 100 %.](10-1055-a-1079-4298-i1635ei3){#FI1635-3}

###### Correct decision making regarding colorectal polypectomy stratified by demographic cohort factors compared to the standards in the ESGE polypectomy guideline.

  Polyp type n (%) \[95 % CI\]   Practitioner type [1](#FN1635-1){ref-type="table-fn"}   Trainee                    Specific endoscopy attachment                                                                                                                          
  ------------------------------ ------------------------------------------------------- -------------------------- ------------------------------- --------------------------- -------------------------- ------- --------------------------- --------------------------- -------
  Small                          277 (44.2) \[40.3--48.1\]                               19 (26.8) \[17.9--38.1\]   0.005                           278 (43.2) \[39.4--47.0\]   24 (38.1) \[27.1--50.5\]   0.437   133 (40.7) \[35.5--46.1\]   169 (44.5) \[39.6--49.5\]   0.308
  Intermediate                   386 (61.6) \[57.7--65.3\]                               45 (63.4) \[51.8--73.6\]   0.765                           398 (61.8) \[58.0--65.5\]   35 (55.6) \[43.3--67.2\]   0.331   213 (65.1) \[59.8--70.1\]   220 (57.9) \[52.9--62.8\]   0.049
  Large                          391 (62.4) \[58.5--66.1\]                               21 (29.6) \[20.2--41.0\]    \< 0.001                       378 (58.7) \[54.9--62.4\]   38 (60.3) \[48.0--71.5\]   0.803   175 (53.5) \[48.1--58.9\]   241 (63.4) \[58.5--68.1\]   0.008
  Predicted SMIC                 484 (77.2) \[73.8--80.3\]                               55 (77.5) \[66.5--85.6\]   0.959                           490 (76.1) \[72.7--79.2\]   57 (90.5) \[80.7--95.6\]   0.009   240 (73.4) \[68.4--77.9\]   307 (80.8) \[76.5--84.4\]   0.019
  Total per subgroup             627                                                     71                                                         644                         63                                 327                         380                         

Polyp size criteria (small, intermediate, large) are defined in the Methods section and in [Fig. 1](#FI1635-1){ref-type="fig"} . Predicted SMIC refers to the 80 mm sigmoid polyp with endoscopic evidence of submucosal invasive cancer (SMIC). Phys, physician; Surg, surgeon; Cons, consultant or independent practitioner; Trainee, not consultant or independent practitioner. Specific endoscopy attachment, undertaken a specific endoscopy training attachment/fellowship for a period of greater than, or including, 6 months. 95%CI, 95 % confidence interval of the proportion above.

*P* values in bold typeface indicate significance at the 0.05 level.

Denominator 698 after removing nurse endoscopists (n = 9).

Small (\< 10 mm) polyps
-----------------------

In total, 302 (42.7 %) participants correctly identified management for both small polyps; 152 (21.5 %) indicated they would remove a 3 mm ascending colon polyp ( [Fig. 2a](#FI1635-2){ref-type="fig"} ) using CBF and 22 (3.1 %) using hot biopsy forceps (HBF); 206 (29.1 %) indicated they would remove an 8 mm ascending colon polyp ( [Fig. 2b](#FI1635-2){ref-type="fig"} ) using HSP and 176 (24.9 %) using EMR.

Surgeons were more likely to remove the 3 mm polyp using HBF (12.7 % versus 2.1 %, *P*  \< 0.001) and less likely to use CSP (36.6 % versus 69.1 %, *P*  \< 0.001) ( [Fig. 3](#FI1635-3){ref-type="fig"} ). Overall, practitioners performing \> 11 colonoscopies/week (46.3 % versus 35.9 %, *P*  = 0.008) and academic practitioners (49.0 % versus 37.7 %, *P*  = 0.003) were more likely to identify correct management and surgeons less likely than physicians (26.8 % versus 44.2 %, *P*  = 0.005) ( [Table 1](#TB1635-1){ref-type="table"} ).

Intermediate (10--19 mm) polyps
-------------------------------

In total, 433 (61.2 %) study participants correctly managed both intermediate sized polyps; 169 (23.9 %) indicated they would remove a 10 mm polyp in the ascending colon ( [Fig. 2c](#FI1635-2){ref-type="fig"} ) using CSP and 105 (14.9 %) using HSP; 88 (12.4 %) would have removed a 15 mm ascending colon polyp ( [Fig. 2 d](#FI1635-2){ref-type="fig"} ) using CSP and 36 (5.1 %) using HSP. Surgeons were more likely to remove the 10 mm polyp using HSP (29.6 % versus 13.4 %, *P*  = 0.006) ( [Fig. 3](#FI1635-3){ref-type="fig"} ).

Large (≥ 20 mm) polyps
----------------------

A total of 416 (58.8 %) participants correctly identified management for all large polyps; 26 (3.7 %) would remove a 20 mm transverse colon polyp ( [Fig. 2e](#FI1635-2){ref-type="fig"} ) using HSP and 10 (1.4 %) using ESD; 125 (17.7 %) would have referred this polyp to another endoscopist for resection and 8 (1.1 %) to a surgeon; 283 (40.0 %) would have performed piecemeal EMR on a 45 mm mid-rectal polyp ( [Fig. 2f](#FI1635-2){ref-type="fig"} ) while 265 (37.5 %) would have referred it to a tertiary endoscopist; 30 (4.2 %) would have performed ESD themselves while 10 (1.4 %) would have attempted HSP; 91 (12.9 %) would have referred it to a surgeon for resection. A minority of respondents would have elected to remove a 45 mm transverse colon polyp ( [Fig. 2 g](#FI1635-2){ref-type="fig"} ) using EMR themselves (180, 25.5 %), with the majority 336 (47.5 %) preferring to refer this polyp to a tertiary endoscopist; 118 (16.7 %) would have referred this polyp to a surgeon for resection.

Surgeons were significantly less likely to make correct decisions regarding large polyps (19, 26.8 % versus 277, 44.2 %, *P*  \< 0.001). In particular, for the two largest polyps, surgeons were more likely to refer for surgical resection than physicians (33.8 % versus 10.2 %, *P*  \< 0.001 and 22.5 % versus 16.1 %, *P*  \< 0.001, respectively) ( [Fig. 3](#FI1635-3){ref-type="fig"} ).

Specifics of large ( ≥ 20 mm) polyp resection or referral
---------------------------------------------------------

Those who indicated they would resect the 45 mm transverse polyp themselves (28 %) were asked if they would biopsy the polyp before resection (15.1 % would) and whether they would remove the polyp in the same session it was detected (28.1 % would) ( [Fig. 4](#FI1635-4){ref-type="fig"} ). The majority (71.9 %) indicated they would perform the procedure at a later date, 41.2 % due to a perceived need for specific consent for this procedure.

![ Management of a large 45 mm laterally spreading polyp in the transverse colon after detection in routine practice. Respondents were shown the image in the top left of the figure and given the management options listed in the table below the image. If they selected to resect the polyp, they were asked biopsy- and consent-related questions ( **a** ). If they selected to refer to another practitioner (endoscopist or surgeon), they were asked questions regarding biopsy and carbon particle suspension marking ( **b** ). Respondents who selected other were invited to comment but were not given the opportunity to answer **a** or **b** . A selection of their comments are presented. EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; MDT, multidisciplinary team.](10-1055-a-1079-4298-i1635ei4){#FI1635-4}

Of those who elected to refer (64 %) the polyp, 47.1 % indicated they would refer to a tertiary endoscopist and 16.7 % to a surgeon. When referring to a surgeon, 88.1 % would have biopsied the polyp and 95.8 % would have marked the position with a carbon particle suspension (tattoo). When referring to a tertiary endoscopist, 35.4 % would have biopsied the polyp and 59.2 % marked the position with tattoo.

In total, 8 % of respondents suggested other management strategies, mainly calling for multidisciplinary discussion before a decision or biopsy before a decision on final management.

Polyp with endoscopic evidence of submucosal invasive cancer (SMIC)
-------------------------------------------------------------------

In total, 360 (50.9 %) participants correctly identified that the 80 mm polyp in the sigmoid colon contained an endoscopically demarcated area consistent with SMIC and suggested surgical referral ( [Fig. 2 h](#FI1635-2){ref-type="fig"} ); 187 (26.4 %) suggested referral to a tertiary endoscopist; 95 (13.4 %) would attempt to remove the polyp themselves, 12.0 % using EMR and 1.4 % using ESD.

Surgeons were more likely to directly refer this polyp to surgery than physicians (69.0 % versus 48.8 %, *P*  \< 0.001) ( [Fig. 3](#FI1635-3){ref-type="fig"} ). Academic practice ( *P*  = 0.025), more than 20 colonoscopies performed per week ( *P*  = 0.049), more than 17 EMRs per year ( *P*  \< 0.001), and 18 + years' total independent practice ( *P*  = 0.046) identified practitioners significantly less likely to identify correct management of this polyp ( [Table 1](#TB1635-1){ref-type="table"} ).

Specific polypectomy techniques
-------------------------------

In total, 508/675 (75.3 %) respondents routinely use carbon dioxide insufflation during colonoscopy and polypectomy ( [Table 2](#TB1635-4){ref-type="table"} ); 423/694 (61.0 %) use a thin wire snare (diameter \<0.4 mm) for CSP.

###### Specific polypectomy techniques identified by respondents. Number of respondents to each question identified separately since not all participants answered all questions, and unlike responses to the questions regarding specific polyps, this did not disqualify their data from analysis.

                                                                                                                                                                 **Respondents**
  -------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------
  **Cold snare polypectomy**                                                                                                                                     
  What type of snare do you use for cold snare polypectomy?                                                                                                      
  Thin wire snare (snare wire diameter \< 0.4 mm)                                                                                                                423 (61.0 %)
  Thick wire snare (snare wire diameter ≥ 0.4 mm)                                                                                                                106 (15.3 %)
  Don't know                                                                                                                                                     165 (23.8 %)
  Total                                                                                                                                                          694
  **Pedunculated polypectomy**                                                                                                                                   
  Do you take routine measures to prevent bleeding from pedunculated polyps with stalk diameter greater than 10 mm?                                              
  Yes                                                                                                                                                            516 (74.6 %)
  No                                                                                                                                                             176 (25.4 %)
  Total                                                                                                                                                          692
  **General polypectomy**                                                                                                                                        
  Do you routinely use carbon dioxide insufflation during colonoscopy and polypectomy?                                                                           
  Yes                                                                                                                                                            508 (75.3 %)
  No                                                                                                                                                             166 (24.6 %)
  Don't know                                                                                                                                                       1 (0.1 %)
  Total                                                                                                                                                          675
  Do you routinely (or frequently) use dye spraying (chromo-endoscopy) to evaluate colon polyps?                                                                 
  Yes                                                                                                                                                            82 (12.2 %)
  No                                                                                                                                                             592 (87.8 %)
  Total                                                                                                                                                          674
  Do you routinely (or frequently) use optical or digital image enhancement (NBI, FICE, etc.) to evaluate colon polyps?                                          
  Yes                                                                                                                                                            497 (73.7 %)
  No                                                                                                                                                             177 (26.3 %)
  Other (please specify)                                                                                                                                           0 (0.0 %)
  Total                                                                                                                                                          674
  Do you perform endoscopic submucosal dissection (ESD) in the rectum?                                                                                           
  Yes                                                                                                                                                             77 (11.4 %)
  No                                                                                                                                                             597 (88.6 %)
  Total                                                                                                                                                          674
  Do you perform ESD in the remainder of the colon?                                                                                                              
  Yes                                                                                                                                                             44 (6.2 %)
  No                                                                                                                                                             629 (89.0 %)
  Total                                                                                                                                                          673 (100.0 %)
  **Submucosal lift polypectomy--(endoscopic mucosal resection--EMR)**                                                                                           
  What size snare do you most commonly use for a standard submucosal lift polypectomy (EMR) in the *right* colon? (proximal and including the hepatic flexure)   
  10 mm                                                                                                                                                          110 (17.1 %)
  15 mm                                                                                                                                                          237 (36.7 %)
  20 mm                                                                                                                                                          172 (26.7 %)
  Other snare size                                                                                                                                                51 (7.9 %)
  Don't know                                                                                                                                                      75 (11.6 %)
  Total                                                                                                                                                          645
  What size snare do you most commonly use for a standard submucosal lift polypectomy (EMR) in the *left* colon? (distal to the hepatic flexure)                 
  10 mm                                                                                                                                                           79 (12.2 %)
  15 mm                                                                                                                                                          218 (33.7 %)
  20 mm                                                                                                                                                          223 (34.5 %)
  Other snare size                                                                                                                                                52 (8.0 %)
  Don't know                                                                                                                                                      74 (11.5 %)
  Total                                                                                                                                                          646
  If you perform submucosal injection before snare resection or EMR, what do you use as the injection solution?                                                  
  Saline                                                                                                                                                         352 (53.3 %)
  Succinylated gelatin (e. g. Gelofusine)                                                                                                                          4 (0.6 %)
  Starch (e. g. Voluven)                                                                                                                                         235 (36.1 %)
  Hyaluronic acid                                                                                                                                                 54 (8.2 %)
  Other                                                                                                                                                           12 (1.8 %)
  Total                                                                                                                                                          660
  Do you routinely add adrenaline/epinephrine to your injection solution for submucosal lift polypectomy (EMR)                                                   
  Yes                                                                                                                                                            274 (40.2 %)
  No                                                                                                                                                             407 (59.8 %)
  Total                                                                                                                                                          681
  Do you routinely add a chromic dye to your injection solution for submucosal lift polypectomy (EMR)?                                                           
  Yes, Indigo Carmine                                                                                                                                            193 (28.1 %)
  Yes, Methylene Blue                                                                                                                                            295 (43.0 %)
  No                                                                                                                                                             185 (27.0 %)
  Other dye                                                                                                                                                       13 (1.9 %)
  Total                                                                                                                                                          686

In total, 516/692 (74.6 %) routinely take measures to prevent bleeding from the stalks of pedunculated polyps with stalk diameter \> 10 mm (most often clip placement over the polyp stalk, 216/516 \[41.9 %\]).

The most common snare diameter reported for EMR was 15mm in the right colon \[237/645, 36.7 %\] and 20 mm in the left colon \[223/644, 34.5 %\]. The most common injection solution was saline (352/660, 53.3 %). Adrenaline/epinephrine was added to the injectate by 407/681 (59.8 %). A chromic dye was added to the injectate by 501/686 (73.0 %), and most commonly this was Methylene Blue (295, 43.0 %).

In total, 77/674 (11.4 %) of respondents reported performing ESD in the rectum and 44/673 (6.2 %) in the rest of the colon.

Variation in polyp analysis and resection techniques between countries
----------------------------------------------------------------------

Australian endoscopists were most likely to identify the correct management of small polyps (77.8 %) and Belgians were the least likely (16.7 %, *P*  \< 0.001) ( **Supplementary Fig. 1** ). For intermediate polyps, Australian endoscopists identified correct management least often (35.8 %) versus Canadians who had the highest rates (76.7 %, *P*  \< 0.001). Large polyp management was most often correctly identified by Australian endoscopists (74.7 %) and least often by those from the United States (34.2%, *P*  \< 0.001). Belgian endoscopists most often correctly suggested management of the polyp with SMIC (84.3 %).

Discussion
==========

Colorectal cancer may be prevented by high-quality colonoscopy and complete polypectomy. It is increasingly recognized that the safety and completeness of polypectomy depend upon the technique used. We analyzed the responses of 707 endoscopists in seven countries to a survey designed to assess their practice against a contemporary synthesis of the available evidence in colorectal polypectomy [@JR1635-11] . The results demonstrate areas for focused interventions to improve polypectomy practice and therefore patient outcomes.

The 2017 ESGE Colorectal Polypectomy Guideline offers an excellent synthesis of the contemporary evidence for technique choice in polypectomy, stratified by polyp size and is freely available from the organization's website. The standards set forth in the guideline had been clear from important publications in peer-reviewed journals on the subject [@JR1635-12] [@JR1635-13] and the accumulating publications on the safety and efficacy of CSP [@JR1635-14] [@JR1635-15] , the risks of HBF [@JR1635-16] [@JR1635-17] , and the efficacy and superior safety profile of endoscopic resection versus surgery [@JR1635-18] [@JR1635-19] [@JR1635-20] [@JR1635-21] over the prior decade. It is incumbent upon all medical practitioners to remain up-to-date with the evidence in their field of practice. Therefore, we used the guideline as a benchmark against which to assess the polypectomy practice of individual endoscopists against the best contemporary evidence at the time of the survey.

The lowest rates of adherence to the guideline were regarding resection of the smallest polyps ( \< 10 mm). CSP is the preferred technique here (CBF considered to be a second-line option for polyps ≥ 3 mm where CSP is "technically difficult"). Recent data reinforce the safety [@JR1635-7] , and efficacy of CSP in achieving en bloc resection and adenoma clearance in addition to its comparative efficacy versus HSP [@JR1635-5] [@JR1635-6] . The small polyps presented were located in the right colon where the risk profile of diathermy is highest.

While encouraging numbers of respondents indicated they would perform CSP or CBF for the 3 mm ascending colon polyp, for an 8 mm polyp in the same location, \> 50 % of respondents indicated they would perform EMR or, of greater concern, HSP (without a submucosal lift) in their daily practice. This suggests unnecessary exposure of patients to the small yet definite risks of diathermy, namely delayed bleeding [@JR1635-22] and post-polypectomy syndrome [@JR1635-15] . A particular focus for the promotion of CSP should be non-academic practitioners performing smaller numbers of colonoscopies since these groups demonstrated lower adherence in this category.

A small number of respondents stated that they would perform HBF to resect the 3 mm ascending colon polyp. Animal [@JR1635-16] and clinical [@JR1635-17] studies suggest HBF should be avoided due to the possibility of full thickness colonic injury and poor rates of complete resection. Surgeons were significantly more likely to suggest HBF as a response. The message that HBF should be avoided must be further promoted in this context.

Higher rates of adherence to the guideline were recorded regarding intermediate (10--19 mm) polyps. HSP (without submucosal injection) or EMR are recommended here but deep thermal injury is a potential risk with HSP and submucosal injection is strongly recommended. Respondents expressed a preference for EMR over HSP in the majority of cases regarding both polyps. Only 15 % indicated they would remove the 10 mm polyp and 5 % the 15 mm right colon polyp with HSP; those responding in this way were more commonly surgeons. Therefore, although the guideline suggests HSP is acceptable, it is clearly not the practice of the majority of study respondents or that of the authors, particularly in the right colon.

Correct management of all large polyps was identified by 60% of respondents overall. Polyps ≥ 20 mm in size (\> 90 %) can be safely and effectively resected in a single session using EMR [@JR1635-20] [@JR1635-23] without resorting to surgery with its higher risk of morbidity and mortality [@JR1635-18] [@JR1635-24] . Therefore patients have much to gain from correct responses in this category.

The majority of respondents suggested endoscopic management for a 20 mm polyp in the transverse colon and felt comfortable undertaking this themselves. Conversely, only 40% suggested they would attempt a 45 mm rectal polyp themselves and 26 % a 45 mm transverse colon polyp. Given the cohort bias, this suggests the majority of endoscopists prefer to refer large laterally spreading polyps to a tertiary endoscopist. Of significant concern, 13 % suggested they would refer the rectal polyp for surgery and 17 % the transverse colon polyp. This is supported by recent US data indicating the rate of surgery for non-malignant colorectal polyps is high (9.4/100 000 adults) and has increased over the past 14 years [@JR1635-25] . Surgeons and non-academic endoscopists were more likely to refer benign disease for surgery. This finding suggests that the establishment of review pathways for endoscopic images of large colorectal polyps by expert endoscopists before surgical referral is necessary.

Almost all respondents indicated they would biopsy and mark a polyp being referred for surgery with tattoo. The authors agree with this practice. If referring to a tertiary endoscopist, only 1/3 would biopsy the polyp (even with "hindsight") and 2/3 would mark the polyp with tattoo. Anecdotal evidence indicates that both practices are associated with fibrosis at endoscopic resection so the authors take a common-sense approach of marking subtle polyps at least 2 cm distally and biopsying only superficially and if there is concern for SMIC.

A third of respondents indicated they would remove the 45mm transverse polyp (if detected on a screening list) at the session it was detected without specific consent. Presuming the patient is sedated, the authors would recommend specific consent be obtained before endoscopic resection of such a polyp. Reasons include the higher rates of delayed bleeding, hospital admission, adenoma recurrence and the need for further surgery than polypectomy of smaller polyps. Patients should also be informed of the available alternative management options including observation, alternative endoscopic techniques, or surgery.

One in four respondents did not recognize that an 80 mm sigmoid polyp contained overt evidence of SMIC and suggested endoscopic resection was appropriate. Interestingly, those with a longer practice duration and academic practice were less likely to answer correctly. Consideration should be given to the development of training schemes incorporating endoscopic imaging for practicing endoscopists to avoid unnecessary repeat procedures for patients (either after tertiary endoscopist referral of an endoscopically unresectable polyp, or due to a failed endoscopic resection attempt of the same).

The technical polypectomy data from the survey provide interesting insights into real-world polypectomy practice when compared to the best available evidence. In particular, 11 % of respondents reported performing ESD in the rectum and 6 % in the remainder of the colon. This demonstrates the expertise bias within the survey cohort but taking this into consideration, also demonstrates that ESD is not performed by the vast majority of endoscopists in the countries surveyed.

This study has some limitations. The response rate to the study was low. In addition, the use of a marketing mailing list for dissemination of the survey in the USA garnered a particularly low response rate and may have biased the results. Before use of a marketing list, we approached the largest endoscopy organization in that country, but it declined to participate.

Studies with similar methodology had response rates of 13--45 % [@JR1635-26] [@JR1635-27] [@JR1635-28] [@JR1635-29] [@JR1635-30] [@JR1635-31] , but significantly lower response pools (maximum 5030 versus 19 467 in this study) and therefore significantly fewer respondents \[excepting the US only study [@JR1635-29] \]. Such a large study on polypectomy with \> 700 complete responses and contributions from seven Western countries has not previously been described. Due to the low response rate, there is a significant risk of non-response bias. To mitigate this as far as possible, multiple, focused questions to address potentially confounding demographics were included in the survey. The responses to these suggested the respondents are a self-selected group with extensive experience and with an interest in endoscopy. The results should be interpreted in this context. Indeed, while this cannot be proven, the practice of non-respondents could reasonably be expected to be less adherent than that of respondents.

Still single images were used for the questions regarding polyp management. While not a substitute for in vivo polyp assessment, similar judgments must often be made from previously acquired images (often single and of low quality) provided for referral purposes. All authors confirmed the polyp images as representative before circulation of the survey. The power of individual, anonymous reporting of images to judge current practice should not be underestimated. Rigid classifications were used to judge adherence of participant responses to guidelines. We acknowledge that individual cases must be judged using clinical acumen, and guidelines are not a substitute for this.

The number of surgeons and trainees in this study was small compared to the overall cohort. Despite this, statistical significance was demonstrated, however, we accept the possibility of bias within the small group of individuals recruited.

Conclusions
===========

Responses of over 700 colonoscopists in seven countries suggest that CSP is underutilized for diminutive polypectomy despite its favorable safety and similar efficacy profile compared to alternative techniques requiring diathermy. Benign colorectal neoplasia is routinely referred for surgery. Overt SMIC is underappreciated using endoscopic imaging amongst a self-selected group of interested endoscopic practitioners. Addressing these issues via focused interventions by international endoscopy societies may reduce burdens of diathermy-related adverse events, surgery, and unnecessary colonoscopic procedures on patients, in addition to potentially reducing rates of PCCRC.

###### Correct decision making regarding colorectal polypectomy stratified by demographic cohort factors compared to the standards in the ESGE polypectomy guideline.

  Polyp type n (%) \[95 % CI\]   Referral                    11 + colons                 20 + colons                                                                                                                           
  ------------------------------ --------------------------- --------------------------- ------------- --------------------------- --------------------------- ------- --------------------------- --------------------------- -------
  Small                          92 (37.9) \[32.0--44.1\]    210 (45.3) \[40.8--49.8\]   0.059         214 (46.3) \[41.8--50.9\]   88 (35.9) \[30.2--42.1\]    0.008   87 (47.5) \[40.4--54.8\]    215 (41.0) \[36.9--45.3\]   0.125
  Intermediate                   164 (67.5) \[63.4--73.1\]   269 (58.0) \[53.4--62.4\]   0.014         292 (63.2) \[58.7--67.5\]   141 (57.6) \[51.3--63.6\]   0.142   105 (57.4) \[50.1--64.3\]   328 (62.6) \[58.4--66.6\]   0.212
  Large                          146 (60.1) \[53.8--66.0\]   270 (58.2) \[53.7--62.6\]   0.627         266 (57.6) \[53.0--62.0\]   150 (61.2) \[55.0--67.1\]   0.348   103 (56.3) \[49.0--63.3\]   313 (59.7) \[55.5--63.8\]   0.414
  Predicted SMIC                 132 (54.3) \[48.0--60.5\]   415 (89.4) \[86.3--92.0\]    \< 0.001     357 (77.3) \[73.2--80.9\]   190 (77.6) \[71.9--82.3\]   0.933   132 (72.1) \[65.2--78.1\]   415 (79.2) \[75.5--82.5\]   0.049
  Total per subgroup             243                         464                                       462                         245                                 183                         524                         

Polyp size criteria (small, intermediate, large) are defined in the Methods section and in [Fig. 1](#FI1635-1){ref-type="fig"} . Predicted SMIC refers to the 80 mm sigmoid polyp with endoscopic evidence of submucosal invasive cancer (SMIC). Referral, practitioner reports receiving referrals for colonoscopic polypectomy; 11 + colons, practitioner reports performing 11 or more colonoscopies per week; 20 + colons, practitioner reports performing 20 or more colonoscopies per week; 95 %CI, 95 % confidence interval of the proportion above.

*P* values in bold typeface indicate significance at the 0.05 level.

###### Correct decision making regarding colorectal polypectomy stratified by demographic cohort factors compared to the standards in the ESGE polypectomy guideline.

  Polyp type n (%) \[95 % CI\]   Academic                    17 + EMRs                   18 + years' practice   Overall                                                                                                                             
  ------------------------------ --------------------------- --------------------------- ---------------------- --------------------------- --------------------------- ----------- --------------------------- --------------------------- ------- ------------
  Small                          153 (49.0) \[43.5--54.6\]   149 (37.7) \[33.1--42.6\]   0.003                  80 (31.5) \[26.1--37.5\]    222 (49.0) \[44.4--53.6\]    \< 0.001   140 (39.7) \[34.7--44.9\]   162 (45.8) \[40.6--51.0\]   0.101   302 (42.7)
  Intermediate                   185 (59.3) \[53.8--64.6\]   248 (62.8) \[57.9--67.4\]   0.344                  189 (74.4) \[68.7--79.4\]   244 (53.9) \[49.3--58.4\]    \< 0.001   220 (62.3) \[57.2--67.2\]   213 (60.2) \[55.0--65.1\]   0.557   433 (61.2)
  Large                          198 (63.5) \[58.0--68.6\]   218 (55.2) \[50.3--60.0\]   0.026                  145 (57.1) \[50.9--63.0\]   271 (59.8) \[55.2--64.2\]   0.478       198 (56.1) \[50.9--61.2\]   218 (61.6) \[56.4--66.5\]   0.138   416 (58.8)
  Predicted SMIC                 229 (73.4) \[68.2--78.0\]   229 (80.5) \[53.1--62.7\]   0.025                  168 (66.1) \[60.1--71.7\]   379 (83.7) \[80.0--86.8\]    \< 0.001   262 (74.2) \[69.4--78.5\]   285 (80.5) \[76.1--84.3\]   0.046   547 (77.4)
  Total per subgroup             312                         395                                                254                         453                                     353                         354                                 707

Polyp size criteria (small, intermediate, large) are defined in the Methods section and in [Fig. 1](#FI1635-1){ref-type="fig"} . Predicted SMIC refers to the 80 mm sigmoid polyp with endoscopic evidence of submucosal invasive cancer (SMIC). Academic, practitioner reports at least part of their practice in an academic institution; 17 + EMRs, practitioner reports performing 17 or more endoscopic mucosal resection procedures for polyps ≥ 20 mm per year; 18 + years' practice, practitioner reports 18 or more years of continuous practice as a consultant or independent practitioner; 95 %CI, 95 % confidence interval of the proportion above.

*P* values in bold typeface indicate significance at the 0.05 level.
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